Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 12, Issue SUPPL.2, 2013, Pages

  Aanæs, Kasper ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Chronic rhinosinusitis; Immune response; Paranasal sinuses; Quality of life; S IgA; Sinus treatments (sinus surgery, nasal irrigation); United airways; Upper airway colonisation (Pseudomonas aeruginosa, Burkholderia cepacia, Achromobacter xylosoxidans)

Indexed keywords

ANTIBIOTIC AGENT; COLISTIMETHATE; MOMETASONE FUROATE;

ACHROMOBACTER XYLOSOXIDANS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SINUSITIS; BLEEDING; BURKHOLDERIA CEPACIA COMPLEX; CYSTIC FIBROSIS; ENDOSCOPIC SINUS SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; LUNG INFECTION; NASAL LAVAGE; NOSE SECRETION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; QUALITY OF LIFE; SALIVA;

CHRONIC RHINOSINUSITIS; IMMUNE RESPONSE; PARANASAL SINUSES; QUALITY OF LIFE; S-IGA; SINUS TREATMENTS (SINUS SURGERY, NASAL IRRIGATION); UNITED AIRWAYS; UPPER AIRWAY COLONISATION (PSEUDOMONAS AERUGINOSA, BURKHOLDERIA CEPACIA, ACHROMOBACTER XYLOSOXIDANS);

CHRONIC DISEASE; CYSTIC FIBROSIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LUNG; LUNG DISEASES; RESPIRATORY TRACT INFECTIONS; SINUSITIS;

EID: 84884366610     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/S1569-1993(13)00150-1     Document Type: Article

References (162)

1. Johansen HK, Aanaes K, Pressler T, Nielsen KG, Fisker J, Skov M, et al. Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros 2012, 11(6):525-531.
2. Aanaes K, Johansen HK, Poulsen SS, Pressler T, von Buchwald C, Høiby N Secretory IgA as a diagnostic tool for Pseudomonas aeruginosa respiratory colonization. J Cyst Fibros 2013, 12(1):81-87.
3. Aanaes K, von Buchwald C, Skov M, Hjuler T, Alanin M, Johansen HK The effect of sinus surgery with intensive follow-up on pathogenic bacteria in patients with cystic fibrosis. Am J Rhinol Allergy 2013, 27(1):e1-e4.
4. Aanaes K, Johansen HK, Skov M, Buchvald F, Hjuler T, Pressler T, et al. Clinical effects of sinus surgery and adjuvant therapy in cystic fibrosis patients - can chronic lung infections be postponed?. Rhinology 2013, 51(3):222-230.
5. Nielsen OH, Thomsen BL, Green A, Andersen PK, Hauge M, Schiøtz PO Cystic fibrosis in Denmark 1945 to 1985. An analysis of incidence, mortality and influence of centralized treatment on survival. Acta Paediatr Scand 1988, 77(6):836-841.
6. Kerem B, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989, 245(4922):1073-1080.
7. Frederiksen B, Koch C, Høiby N Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995). Pediatr Pulmonol 1999, 28(3):159-166.
8. Boucher RC New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Respir J 2004, 23(1):146-158.
9. Rubin BK Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev 2007, 8(1):4-7.
10. Cystic Fibrosis Foundation. Patient Registry 2007 Annual Report. 2009.
11. Koch C, Høiby N Diagnosis and treatment of cystic fibrosis. Respiration 2000, 67(3):239-247.
12. Döring G Host response to Pseudomonas aeruginosa. Acta Paediatr Scand Suppl 1989, 363:37-39.
13. Høiby N, Flensborg EW, Beck B, Friis B, Jacobsen SV, Jacobsen L Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand J Respir Dis 1977, 58(2):65-79.
14. Bech B, Pressler T, Iversen M, Carlsen J, Milman N, Eliasen K, et al. Long-term outcome of lung transplantation for cystic fibrosis - Danish results. Eur J Cardiothorac Surg 2004, 26(6):1180-1186.
15. Høiby N Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol Microbiol Scand B Microbiol Immunol 1974, 82(4):541-550.
16. Høiby N Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response. Acta Pathol Microbiol Scand B Microbiol Immunol 1974, 82(4):551-558.
17. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2(1):29-34.
18. Brett MM, Ghoneim AT, Littlewood JM Prediction and diagnosis of early Pseudomonas aeruginosa infection in cystic fibrosis: a follow-up study. J Clin Microbiol 1988, 26(8):1565-1570.
19. Pressler T, Karpati F, Granstrom M, Knudsen PK, Lindblad A, Hjelte L, et al. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J Cyst Fibros 2009, 8(1):37-42.
20. Proesmans M, Balinska-Miskiewicz W, Dupont L, Bossuyt X, Verhaegen J, Høiby N, et al. Evaluating the "Leeds criteria" for Pseudomonas aeruginosa infection in a cystic fibrosis centre. Eur Respir J 2006, 27(5):937-943.
21. Hansen CR, Pressler T, Høiby N Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros 2008, 7(6):523-530.
22. Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van GM, et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax 2010, 65(1):57-62.
23. Aanaes K, Rickelt LF, Johansen HK, Buchwald C, Pressler T, Høiby N, et al. Decreased mucosal oxygen tension in the maxillary sinuses in patients with cystic fibrosis. J Cyst Fibros 2011, 10(2):114-120.
24. Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, et al. Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 2012, 6(1):31-45.
25. Yang L, Jelsbak L, Molin S Microbial ecology and adaptation in cystic fibrosis airways. Environ Microbiol 2011, 13(7):1682-1689.
26. Høiby N The serology of Pseudomonas aeruginosa analysed by means of quantitative immunoelectrophoretic methods. I. Comparison of thirteen O groups of Ps. aeruginosa, with a polyvalent Ps. aeruginosa antigen-antibody reference system 5. Acta Pathol Microbiol Scand B 1975, 83(4):321-327.
27. Bryan LE, Kureishi A, Rabin HR Detection of antibodies to Pseudomonas aeruginosa alginate extracellular polysaccharide in animals and cystic fibrosis patients by enzyme-linked immunosorbent assay. J Clin Microbiol 1983, 18(2):276-282.
28. Pedersen SS, Moller H, Espersen F, Sorensen CH, Jensen T, Høiby N Mucosal immunity to Pseudomonas aeruginosa alginate in cystic fibrosis. APMIS 1992, 100(4):326-334.
29. Johansen HK, Høiby N Local IgA and IgG response to intratracheal immunization with Pseudomonas aeruginosa antigens. APMIS 1992, 100(1):87-90.
30. Hansen CR, Pressler T, Nielsen KG, Jensen PO, Bjarnsholt T, Høiby N Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 2010, 9(1):51-58.
31. Magni A, Giordano A, Mancini C, Pecoraro C, Varesi P, Quattrucci S, et al. Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance. New Microbiol 2007, 30(1):59-62.
32. Waters V New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. Curr Pharm Des 2012, 18(5):696-725.
33. Braccini G, Festini F, Boni V, Neri AS, Galici V, Campana S, et al. The costs of treatment of early and chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Chemother 2009, 21(2):188-192.
34. Döring G, Høiby N Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004, 3(2):67-91.
35. Frederiksen B, Koch C, Høiby N Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol 1997, 23(5):330-335.
36. Ratjen F, Walter H, Haug M, Meisner C, Grasemann H, Döring G Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr Pulmonol 2007, 42(3):249-255.
37. da Silva Filho LV, Tateno AF, Martins KM, Azzuz Chernishev AC, Garcia DO, Haug M, et al. The combination of PCR and serology increases the diagnosis of Pseudomonas aeruginosa colonization/infection in cystic fibrosis. Pediatr Pulmonol 2007, 42(10):938-944.
38. De BK, Alifier M, Vandeputte S Sputum induction in young cystic fibrosis patients. Eur Respir J 2000, 16(1):91-94.
39. Wood RE The diagnostic effectiveness of the flexible bronchoscope in children. Pediatr Pulmonol 1985, 1(4):188-192.
40. Pressler T, Frederiksen B, Skov M, Garred P, Koch C, Høiby N Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection - a case control study. J Cyst Fibros 2006, 5(1):9-15.
41. Johansen HK, Norregaard L, Gotzsche PC, Pressler T, Koch C, Høiby N Antibody response to Pseudomonas aeruginosa in cystic fibrosis patients: a marker of therapeutic success? - A 30-year cohort study of survival in Danish CF patients after onset of chronic P. aeruginosa lung infection. Pediatr Pulmonol 2004, 37(5):427-432.
42. Eggesbo HB, Sovik S, Dolvik S, Kolmannskog F CT characterization of inflammatory paranasal sinus disease in cystic fibrosis. Acta Radiol 2002, 43(1):21-28.
43. Mainz JG, Koitschev A Management of chronic rhinosinusitis in CF. J Cyst Fibros 2009, 8(Suppl 1):S10-S14.
44. Mak GK, Henig NR Sinus disease in cystic fibrosis. Clin Rev Allergy Immunol 2001, 21(1):51-63.
45. Robertson JM, Friedman EM, Rubin BK Nasal and sinus disease in cystic fibrosis. Paediatr Respir Rev 2008, 9(3):213-219.
46. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 2012, 50(1):1-12.
47. Loebinger MR, Bilton D, Wilson R Upper airway 2: Bronchiectasis, cystic fibrosis and sinusitis. Thorax 2009, 64(12):1096-1101.
48. Cepero R, Smith RJ, Catlin FI, Bressler KL, Furuta GT, Shandera KC Cystic fibrosis - an otolaryngologic perspective. Otolaryngol Head Neck Surg 1987, 97(4):356-360.
49. Eggesbo HB, Sovik S, Dolvik S, Eiklid K, Kolmannskog F CT characterization of developmental variations of the paranasal sinuses in cystic fibrosis. Acta Radiol 2001, 42(5):482-493.
50. Eggesbo HB, Dolvik S, Stiris M, Sovik S, Storrosten OT, Kolmannskog F Complementary role of MR imaging of ethmomaxillary sinus disease depicted at CT in cystic fibrosis. Acta Radiol 2001, 42(2):144-150.
51. Eggesbo HB, Sovik S, Dolvik S, Eiklid K, Kolmannskog F Proposal of a CT scoring system of the paranasal sinuses in diagnosing cystic fibrosis. Eur Radiol 2003, 13(6):1451-1460.
52. Gysin C, Alothman GA, Papsin BC Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management. Pediatr Pulmonol 2000, 30(6):481-489.
53. Rasmussen J, Aanaes K, Norling R, Nielsen KG, Johansen HK, Buchwald C CT of the paranasal sinuses is not a valid indicator for sinus surgery in CF patients. J Cyst Fibros 2012, 11(2):93-99.
54. Halvorson DJ Cystic fibrosis: an update for the otolaryngologist. Otolaryngol Head Neck Surg 1999, 120(4):502-506.
55. Stern RC, Boat TF, Wood RE, Matthews LW, Doershuk CF Treatment and prognosis of nasal polyps in cystic fibrosis. Am J Dis Child 1982, 136(12):1067-1070.
56. Friedman EM, Stewart M An assessment of sinus quality of life and pulmonary function in children with cystic fibrosis. Am J Rhinol 2006, 20(6):568-572.
57. Henriksson G, Westrin KM, Karpati F, Wikstrom AC, Stierna P, Hjelte L Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest 2002, 121(1):40-47.
58. Kingdom TT, Lee KC, FitzSimmons SC, Cropp GJ Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyposis requiring surgery. Arch Otolaryngol Head Neck Surg 1996, 122(11):1209-1213.
59. Feuillet-Fieux MN, Lenoir G, Sermet I, Elie C, Djadi-Prat J, Ferrec M, et al. Nasal polyposis and cystic fibrosis (CF): review of the literature. Rhinology 2011, 49(3):347-355.
60. Coste A, Gilain L, Roger G, Sebbagh G, Lenoir G, Manach Y, et al. Endoscopic and CT-scan evaluation of rhinosinusitis in cystic fibrosis. Rhinology 1995, 33(3):152-156.
61. King VV Upper respiratory disease, sinusitis, and polyposis. Clin Rev Allergy 1991, 9(1-2):143-157.
62. Bonestroo HJ, de Winter-de Groot KM, van der Ent CK, Arets HG Upper and lower airway cultures in children with cystic fibrosis: do not neglect the upper airways. J Cyst Fibros 2010, 9(2):130-134.
63. Watelet JB, Van CP, Bachert C Rhinological aspects of cystic fibrosis. Monaldi Arch Chest Dis 2000, 55(6):475-477.
64. Alobid I, Benitez P, Bernal-Sprekelsen M, Roca J, Alonso J, Picado C, et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 2005, 60(4):452-458.
65. Sahlstrand-Johnson P, Ohlsson B, Buchwald C, Jannert M A multi-centre study on quality of life and absenteeism in patients with CRS referred for endoscopic surgery. Rhinology 2011, 49(4):420-428.
66. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol 2009, 34(5):447-454.
67. Kay DJ, Rosenfeld RM Quality of life for children with persistent sinonasal symptoms. Otolaryngol Head Neck Surg 2003, 128(1):17-26.
68. Clinical practice guideline: management of sinusitis. Pediatrics 2001, 108(3):798-808.
69. Brook I Microbiology of sinusitis. Proc Am Thorac Soc 2011, 8(1):90-100.
70. Digoy GP, Dunn JD, Stoner JA, Christie A, Jones DT Bacteriology of the paranasal sinuses in pediatric cystic fibrosis patients. Int J Pediatr Otorhinolaryngol 2012, 76(7):934-938.
71. Mainz JG, Naehrlich L, Schien M, Kading M, Schiller I, Mayr S, et al. Concordant genotype of upper and lower airways P. aeruginosa and S. aureus isolates in cystic fibrosis. Thorax 2009, 64(6):535-540.
72. Moss RB, King VV Management of sinusitis in cystic fibrosis by endoscopic surgery and serial antimicrobial lavage. Reduction in recurrence requiring surgery. Arch Otolaryngol Head Neck Surg 1995, 121(5):566-572.
73. Shapiro ED, Milmoe GJ, Wald ER, Rodnan JB, Bowen AD Bacteriology of the maxillary sinuses in patients with cystic fibrosis. J Infect Dis 1982, 146(5):589-593.
74. Wise SK, Kingdom TT, McKean L, DelGaudio JM, Venkatraman G Presence of fungus in sinus cultures of cystic fibrosis patients. Am J Rhinol 2005, 19(1):47-51.
75. Muhlebach MS, Miller MB, Moore C, Wedd JP, Drake AF, Leigh MW Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis?. Pediatr Pulmonol 2006, 41(5):445-451.
76. Roby BB, McNamara J, Finkelstein M, Sidman J Sinus surgery in cystic fibrosis patients: comparison of sinus and lower airway cultures. Int J Pediatr Otorhinolaryngol 2008, 72(9):1365-1369.
77. Suh JD, Cohen NA, Palmer JN Biofilms in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2010, 18(1):27-31.
78. Bjarnsholt T, Jensen PO, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 2009, 44(6):547-558.
79. Dosanjh A, Lakhani S, Elashoff D, Chin C, Hsu V, Hilman B A comparison of microbiologic flora of the sinuses and airway among cystic fibrosis patients with maxillary antrostomies. Pediatr Transplant 2000, 4(3):182-185.
80. Taylor L, Corey M, Matlow A, Sweezey NB, Ratjen F Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis. Pediatr Pulmonol 2006, 41(9):839-843.
81. Godoy JM, Godoy AN, Ribalta G, Largo I Bacterial pattern in chronic sinusitis and cystic fibrosis. Otolaryngol Head Neck Surg 2011, 145(4):673-676.
82. Davidson TM, Murphy C, Mitchell M, Smith C, Light M Management of chronic sinusitis in cystic fibrosis. Laryngoscope 1995, 105(4 Pt 1):354-358.
83. Jung A, Kleinau I, Schonian G, Bauernfeind A, Chen C, Griese M, et al. Sequential genotyping of Pseudomonas aeruginosa from upper and lower airways of cystic fibrosis patients. Eur Respir J 2002, 20(6):1457-1463.
84. Taylor-Robinson D, Whitehead M, Diderichsen F, Olesen HV, Pressler T, Smyth RL, et al. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax 2012, 67(10):860-866.
85. Taylor RF, Morgan DW, Nicholson PS, Mackay IS, Hodson ME, Pitt TL Extrapulmonary sites of Pseudomonas aeruginosa in adults with cystic fibrosis. Thorax 1992, 47(6):426-428.
86. Walter S, Gudowius P, Bosshammer J, Romling U, Weissbrodt H, Schurmann W, et al. Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis. Thorax 1997, 52(4):318-321.
87. Jelsbak L, Johansen HK, Frost AL, Thogersen R, Thomsen LE, Ciofu O, et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun 2007, 75(5):2214-2224.
88. Munck A, Bonacorsi S, Mariani-Kurkdjian P, Lebourgeois M, Gerardin M, Brahimi N, et al. Genotypic characterization of Pseudomonas aeruginosa strains recovered from patients with cystic fibrosis after initial and subsequent colonization. Pediatr Pulmonol 2001, 32(4):288-292.
89. Taccetti G, Campana S, Festini F, Mascherini M, Döring G Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005, 26(3):458-461.
90. Høiby N, Pedersen SS Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand 1989, 78(3):395-404.
91. Johansen HK, Høiby N Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark. Thorax 1992, 47(2):109-111.
92. Holzmann D, Speich R, Kaufmann T, Laube I, Russi EW, Simmen D, et al. Effects of sinus surgery in patients with cystic fibrosis after lung transplantation: a 10-year experience. Transplantation 2004, 77(1):134-136.
93. Khalil HS, Nunez DA Functional endoscopic sinus surgery for chronic rhinosinusitis. Cochrane Database Syst Rev 2006, (3). CD004458.
94. Vital D, Hofer M, Boehler A, Holzmann D Posttransplant sinus surgery in lung transplant recipients with cystic fibrosis: a single institutional experience. Eur Arch Otorhinolaryngol 2013, 270(1):135-139.
95. Vital D, Hofer M, Benden C, Holzmann D, Boehler A Impact of sinus surgery on pseudomonal airway colonization, bronchiolitis obliterans syndrome and survival in cystic fibrosis lung transplant recipients. Respiration 2013, 86(1):25-31.
96. Shatz A Management of recurrent sinus disease in children with cystic fibrosis: a combined approach. Otolaryngol Head Neck Surg 2006, 135(2):248-252.
97. Lewiston N, King V, Umetsu D, Starnes V, Marshall S, Kramer M, et al. Cystic fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus antrostomy and repeated sinus lavage. Transplant Proc 1991, 23(1 Pt 2):1207-1208.
98. Shekelle PG, Woolf SH, Eccles M, Grimshaw J Developing clinical guidelines. West J Med 1999, 170(6):348-351.
99. Jarrett WA, Militsakh O, Anstad M, Manaligod J Endoscopic sinus surgery in cystic fibrosis: effects on pulmonary function and ideal body weight. Ear Nose Throat J 2004, 83(2):118-121.
100. Leung MK, Rachakonda L, Weill D, Hwang PH Effects of sinus surgery on lung transplantation outcomes in cystic fibrosis. Am J Rhinol 2008, 22(2):192-196.
101. Madonna D, Isaacson G, Rosenfeld RM, Panitch H Effect of sinus surgery on pulmonary function in patients with cystic fibrosis. Laryngoscope 1997, 107(3):328-331.
102. Osborn AJ, Leung R, Ratjen F, James AL Effect of endoscopic sinus surgery on pulmonary function and microbial pathogens in a pediatric population with cystic fibrosis. Arch Otolaryngol Head Neck Surg 2011, 137(6):542-547.
103. Rosbe KW, Jones DT, Rahbar R, Lahiri T, Auerbach AD Endoscopic sinus surgery in cystic fibrosis: do patients benefit from surgery?. Int J Pediatr Otorhinolaryngol 2001, 61(2):113-119.
104. Triglia JM, Nicollas R Nasal and sinus polyposis in children. Laryngoscope 1997, 107(7):963-966.
105. Umetsu DT, Moss RB, King VV, Lewiston NJ Sinus disease in patients with severe cystic fibrosis: relation to pulmonary exacerbation. Lancet 1990, 335(8697):1077-1078.
106. Kempainen RR, Sajan JA, Pylkas AM, Dunitz JM, Rimell FL, Milla CE Effect of endoscopic sinus surgery on pulmonary status of adults with cystic fibrosis. Otolaryngol Head Neck Surg 2012, 147(3):557-562.
107. Halvorson DJ, Dupree JR, Porubsky ES Management of chronic sinusitis in the adult cystic fibrosis patient. Ann Otol Rhinol Laryngol 1998, 107(11 Pt 1):946-952.
108. Kovell LC, Wang J, Ishman SL, Zeitlin PL, Boss EF Cystic fibrosis and sinusitis in children: outcomes and socioeconomic status. Otolaryngol Head Neck Surg 2011, 145(1):146-153.
109. McMurphy AB, Morriss C, Roberts DB, Friedman EM The usefulness of computed tomography scans in cystic fibrosis patients with chronic sinusitis. Am J Rhinol 2007, 21(6):706-710.
110. Graham SM, Launspach JL, Welsh MJ, Zabner J Sequential magnetic resonance imaging analysis of the maxillary sinuses: implications for a model of gene therapy in cystic fibrosis. J Laryngol Otol 1999, 113(4):329-335.
111. Gwaltney JM Acute community-acquired sinusitis. Clin Infect Dis 1996, 23(6):1209-1223.
112. Araujo E, Palombini BC, Cantarelli V, Pereira A, Mariante A Microbiology of middle meatus in chronic rhinosinusitis. Am J Rhinol 2003, 17(1):9-15.
113. Cheng K, Ashby D, Smyth RL Oral steroids for long-term use in cystic fibrosis. Cochrane Database Syst Rev 2011, (10). CD000407.
114. Becker SS, Rasamny JK, Han JK, Patrie J, Gross CW Steroid injection for sinonasal polyps: the University of Virginia experience. Am J Rhinol 2007, 21(1):64-69.
115. Sorensen H, Mygind N, Tygstrup I, Winge FE Histology of nasal polyps of different etiology. Rhinology 1977, 15(3):121-128.
116. Costantini D, Di Cicco M, Giunta A, Amabile G Nasal polyposis in cystic fibrosis treated by beclomethasone dipropionate. Acta Univ Carol Med (Praha) 1990, 36(1-4):220-221.
117. Hadfield PJ, Rowe-Jones JM, Mackay IS A prospective treatment trial of nasal polyps in adults with cystic fibrosis. Rhinology 2000, 38(2):63-65.
118. Weber SA, Ferrari GF Incidence and evolution of nasal polyps in children and adolescents with cystic fibrosis. Braz J Otorhinolaryngol 2008, 74(1):16-20.
119. Cuyler JP Follow-up of endoscopic sinus surgery on children with cystic fibrosis. Arch Otolaryngol Head Neck Surg 1992, 118(5):505-506.
120. Nishioka GJ, Barbero GJ, Konig P, Parsons DS, Cook PR, Davis WE Symptom outcome after functional endoscopic sinus surgery in patients with cystic fibrosis: a prospective study. Otolaryngol Head Neck Surg 1995, 113(4):440-445.
121. Rowe-Jones JM, Mackay IS Endoscopic sinus surgery in the treatment of cystic fibrosis with nasal polyposis. Laryngoscope 1996, 106(12 Pt 1):1540-1544.
122. Keck T, Rozsasi A Medium-term symptom outcomes after paranasal sinus surgery in children and young adults with cystic fibrosis. Laryngoscope 2007, 117(3):475-479.
123. Jones JW, Parsons DS, Cuyler JP The results of functional endoscopic sinus (FES) surgery on the symptoms of patients with cystic fibrosis. Int J Pediatr Otorhinolaryngol 1993, 28(1):25-32.
124. Yung MW, Gould J, Upton GJ Nasal polyposis in children with cystic fibrosis: a long-term follow-up study. Ann Otol Rhinol Laryngol 2002, 111(12 Pt 1):1081-1086.
125. Bugten V, Nordgard S, Steinsvag S The effects of debridement after endoscopic sinus surgery. Laryngoscope 2006, 116(11):2037-2043.
126. Cho DY, Hwang PH Results of endoscopic maxillary mega-antrostomy in recalcitrant maxillary sinusitis. Am J Rhinol 2008, 22(6):658-662.
127. Fuchsmann C, Ayari S, Reix P, Colreavy M, Bellon G, Durieux I, et al. Contribution of CT-assisted navigation and microdebriders to endoscopic sinus surgery in cystic fibrosis. Int J Pediatr Otorhinolaryngol 2008, 72(3):343-349.
128. Virgin FW, Rowe SM, Wade MB, Gaggar A, Leon KJ, Young KR, et al. Extensive surgical and comprehensive postoperative medical management for cystic fibrosis chronic rhinosinusitis. Am J Rhinol Allergy 2012, 26(1):70-75.
129. Crockett DM, McGill TJ, Healy GB, Friedman EM, Salkeld LJ Nasal and paranasal sinus surgery in children with cystic fibrosis. Ann Otol Rhinol Laryngol 1987, 96(4):367-372.
130. Georgalas C, Hansen F, Videler WJ, Fokkens WJ Long terms results of Draf type III (modified endoscopic Lothrop) frontal sinus drainage procedure in 122 patients: a single centre experience. Rhinology 2011, 49(2):195-201.
131. Lamberty JM, Rubin BK The management of anaesthesia for patients with cystic fibrosis. Anaesthesia 1985, 40(5):448-459.
132. Harvey R, Hannan SA, Badia L, Scadding G Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007, (3). CD006394.
133. Boek WM, Keles N, Graamans K, Huizing EH Physiologic and hypertonic saline solutions impair ciliary activity in vitro. Laryngoscope 1999, 109(3):396-399.
134. Wark PA, McDonald V, Jones AP Nebulised hypertonic saline for cystic fibrosis. Cochrane Database Syst Rev 2005, (3). CD001506.
135. Pynnonen MA, Mukerji SS, Kim HM, Adams ME, Terrell JE Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg 2007, 133(11):1115-1120.
136. Chiu AG, Palmer JN, Woodworth BA, Doghramji L, Cohen MB, Prince A, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol 2008, 22(1):34-37.
137. Isaacs S, Fakhri S, Luong A, Whited C, Citardi MJ The effect of dilute baby shampoo on nasal mucociliary clearance in healthy subjects. Am J Rhinol Allergy 2011, 25(1):e27-e29.
138. Cimmino M, Nardone M, Cavaliere M, Plantulli A, Sepe A, Esposito V, et al. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease. Arch Otolaryngol Head Neck Surg 2005, 131(12):1097-1101.
139. Mainz JG, Schiller I, Ritschel C, Mentzel HJ, Riethmuller J, Koitschev A, et al. Sinonasal inhalation of dornase alfa in CF: a double-blind placebo-controlled cross-over pilot trial. Auris Nasus Larynx 2011, 38(2):220-227.
140. Raynor EM, Butler A, Guill M, Bent JP Nasally inhaled dornase alfa in the postoperative management of chronic sinusitis due to cystic fibrosis. Arch Otolaryngol Head Neck Surg 2000, 126(5):581-583.
141. Kobayashi T, Baba S Topical use of antibiotics for paranasal sinusitis. Rhinol Suppl 1992, 14:77-81.
142. Adappa ND, Wei CC, Palmer JN Nasal irrigation with or without drugs: the evidence. Curr Opin Otolaryngol Head Neck Surg 2012, 20(1):53-57.
143. Hansen FS, Djupesland PG, Fokkens WJ Preliminary efficacy of fluticasone delivered by a novel device in recalcitrant chronic rhinosinusitis. Rhinology 2010, 48(3):292-299.
144. Karosi T, Sziklai I, Csomor P Low-frequency ultrasound for biofilm disruption in chronic rhinosinusitis with nasal polyposis: In vitro pilot study. Laryngoscope 2013, 123(1):17-23.
145. Høiby N, Frederiksen B Microbiology of cystic fibrosis. Cystic Fibrosis 2000, 83-107. Arnold, London. 2nd edition. M.E.G.D. Hodson (Ed.).
146. Johansen HK, Moskowitz SM, Ciofu O, Pressler T, Høiby N Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 2008, 7(5):391-397.
147. Pedersen SS, Espersen F, Høiby N, Jensen T Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis. J Clin Microbiol 1990, 28(4):747-755.
148. Hankinson JL, Odencrantz JR, Fedan KB Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159(1):179-187.
149. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993, 15(2):75-88.
150. Nysom K, Molgaard C, Hutchings B, Michaelsen KF Body mass index of 0 to 45-y-old Danes: reference values and comparison with published European reference values. Int J Obes Relat Metab Disord 2001, 25(2):177-184.
151. Quittner AL, Buu A, Messer MA, Modi AC, Watrous M Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 2005, 128(4):2347-2354.
152. Knutsen AP, Slavin RG Allergic bronchopulmonary aspergillosis in asthma and cystic fibrosis. Clin Dev Immunol 2011, 2011:843763.
153. Rozsasi A, Keck T Lipopolysaccharide induction of cyclooxygenase-2 in long-term nasal epithelial cultures in cystic fibrosis. Arch Otolaryngol Head Neck Surg 2010, 136(4):335-339.
154. Tiddens HA Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002, 34(3):228-231.
155. Aanaes K, Rasmussen N, Pressler T, Segelmark M, Johansen HK, Lindberg U, et al. Extensive endoscopic image-guided sinus surgery decreases BPI-ANCA in patients with cystic fibrosis. Scand J Immunol 2012, 76(6):573-579.
156. Grobler A, Weitzel EK, Buele A, Jardeleza C, Cheong YC, Field J, et al. Pre- and postoperative sinus penetration of nasal irrigation. Laryngoscope 2008, 118(11):2078-2081.
157. Singhal D, Weitzel EK, Lin E, Feldt B, Kriete B, McMains KC, et al. Effect of head position and surgical dissection on sinus irrigant penetration in cadavers. Laryngoscope 2010, 120(12):2528-2531.
158. Mainz JG, Michl R, Pfister W, Beck JF Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation. Am J Respir Crit Care Med 2011, 184(9):1089-1090.
159. Herrmann G, Yang L, Wu H, Song Z, Wang H, Høiby N, et al. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa. J Infect Dis 2010, 202(10):1585-1592.
160. Pedersen SS Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. APMIS 1992, 1000(Suppl 28):1-79.
161. Robey RR A five-phase model for clinical-outcome research. J Commun Disord 2004, 37(5):401-411.
162. Campbell R Managing upper respiratory tract complications of primary ciliary dyskinesia in children. Curr Opin Allergy Clin Immunol 2012, 12(1):32-38.